Preventing and treating azole-resistant oropharyngeal candidiasis in HIV-infected patients.
Penzak
S R
SR
Department of Pharmacy Practice, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock 72205-7122, USA.
Gubbins
P O
PO
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000935:Antifungal Agents / Q000627:therapeutic use*; D002180:Candidiasis, Oral / Q000517:prevention & control*; D004352:Drug Resistance, Microbial; D015725:Fluconazole / Q000627:therapeutic use; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D014230:Triazoles / Q000627:therapeutic use*
D000935:Antifungal Agents; D014230:Triazoles; D017964:Itraconazole; D015725:Fluconazole